BPI Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
The cytotoxic action of BPI is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa.
Synonyms
RBPI; BPIFD1; CAP 57; BPI; Bactericidal permeability-increasing protein.
Gene ID
671
Swiss Prot
P17213
Cellular Locus
Cytoplasm, Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
BPI
Clonality
Recombinant
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human BPI
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
671
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
032360-ML750 100 µL
B3GNT7, ID (B3GNT7, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7) (MaxLight 750) discontinued
Ask
View Details 
GTR15355457 1 Vial
Lentiviral human SLC12A8 sgRNA gene knockout kit - Lentiviral human SLC12A8 sgRNA gene knockout kit (25)
Ask
View Details